TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $40,793,000 | +180.6% | 542,100 | +0.1% | 0.04% | +227.3% |
| Q1 2022 | $14,540,000 | -44.0% | 541,510 | -0.5% | 0.01% | -38.9% |
| Q4 2021 | $25,949,000 | -24.8% | 544,010 | +4.7% | 0.02% | -25.0% |
| Q3 2021 | $34,519,000 | -15.2% | 519,630 | -0.4% | 0.02% | -11.1% |
| Q2 2021 | $40,692,000 | -7.7% | 521,560 | +11.9% | 0.03% | -12.9% |
| Q1 2021 | $44,102,000 | -19.8% | 466,240 | +3.3% | 0.03% | -24.4% |
| Q4 2020 | $54,996,000 | +42.6% | 451,340 | +2.2% | 0.04% | +28.1% |
| Q3 2020 | $38,578,000 | +31.3% | 441,600 | -2.9% | 0.03% | +28.0% |
| Q2 2020 | $29,388,000 | – | 455,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |